Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD – Get Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 11,200 shares, an increase of 75.0% from the September 30th total of 6,400 shares. Approximately 0.3% of the shares of the stock are short sold. Based […]